Quebec becomes the first province to publicly reimburse Ojjaara for the treatment of myelofibrosis in adults who have moderate to severe anemia

CNW/ - GSK Canada is pleased to announce that Ojjaara (momelotinib) will now be reimbursed by Régie de l'assurance maladie du ...